Julie G. J.
- Country
- France
- Department
- Service hematologie clinique
Research Overview
Data & Insights
Has run more than one trial at 19 of 133 partner sites.
Specializations
Hematologic Oncology
The investigator specializes in treating acute lymphoblastic leukemia (ALL), with particular emphasis on developing innovative therapeutic approaches for adult patients.
- B-cell precursor ALL
- T-cell ALL
- Philadelphia chromosome-positive B-ALL
Their research encompasses both high-risk and standard-risk patient populations, focusing on optimizing treatment outcomes in adults aged 18-65 years.
Immunotherapy
The investigator explores novel immunotherapeutic strategies in leukemia treatment, incorporating cutting-edge therapeutic agents to enhance treatment efficacy.
- Blinatumomab therapy
- Isatuximab applications
- Targeted immunological approaches
Their work focuses on integrating these agents into frontline therapy protocols for newly diagnosed patients.
Stem Cell Therapy
The investigator studies allogeneic hematopoietic stem cell transplantation (HSCT) in leukemia treatment, working to refine and optimize transplantation protocols.
- Transplantation timing optimization
- Patient selection criteria
- Risk-adapted transplant strategies
Their research aims to determine optimal HSCT indications for different patient subgroups.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.